Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05887479

The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital · Academic / Other
Sex
All
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The patients between the ages of 35-80 who developed spasticity in the upper extremity after stroke will be included.. Botulinum toxin(BT-A) injection will be applied to the study group(n=16) and placebo injection to the control group(n=15) in addition to conventional rehabilitation and stretching exercises. Evaluations will be made before the treatment, in the 2nd week, and in 3rd month after the treatment. Pain relief will be evaluated with the Visual Analog Scale(VAS) and spasticity assessment will be done with the Modified Ashworth Scale(MAS). The functionality will be evaluated with Fugl Meyer Assessment Scale(FMAS) and Box Block Test(BBT).

Conditions

Interventions

TypeNameDescription
DRUGBotulinum toxin type AToxin of Clostridium Botulinum
DRUG%0,9 NaCl%0,9 NaCl

Timeline

Start date
2023-05-25
Primary completion
2023-07-15
Completion
2023-08-15
First posted
2023-06-02
Last updated
2023-11-22

Source: ClinicalTrials.gov record NCT05887479. Inclusion in this directory is not an endorsement.